The FDA gives the green light to the first gene therapy for deafness
Source: NPR Topics: News · Bias: Center
Summary
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Related Coverage
- Melania gives Congress private deadline as she works around Trump's team: report (Far Left — Raw Story)
- Iran’s supreme leader bails on first day of late dad’s funeral ceremonies (Right — New York Post)
- First Thing: Iran to show defiance in six-day funeral for supreme leader (Center Left — US news | The Guardian)
- Zohran Mamdani gives speech to mark US’s 250th birthday in New York – watch in full (Center Left — US news | The Guardian)
- E Pluribus Algae: Why Green Pond Scum Is as American as Red, White and Blue (Center Left — NYT > U.S. > Politics)
- See first glimpse of Taylor Swift and Travis Kelce’s wedding rehearsal decor (Right — New York Post)
- Before 1776: Rediscovering America’s first chapter at Jamestown (Center Right — Washington Examiner)
- DOJ Accidentally Gives Jack Smith Report to Person They’re Suing (Left — The New Republic)
Daily Analysis
Read the full Parallax Pulse for April 23, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From April 23, 2026
- Debate Night Live: Race for California governor (Center)
- Republicans 'ceded competence': Ex-conservative nails GOP for digging their own grave (Left)
- Anthropic: No "kill switch" for AI in classified settings (Center Left)
- Senate GOP launches all-night vote-a-rama to fund ICE, Border Patrol through end of Trump's term (Right)
- Two GOP senators break ranks on final Senate budget vote (Center)








